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A 19-year-old woman presented to a district-level emergency centre 
(EC) 1 hour after an intentional ‘unquantifiable’ metformin overdose. 
Clinical examination at that time was unremarkable except for a 
respiratory rate (RR) of 28  breaths per minute (bpm). No specific 
toxidrome was identified. 
In the EC, 6 hours post metformin ingestion, she appeared restless 
and complained of severe abdominal pain for which ranitidine, hyoscine 
butylbromide and lorazepam were administered orally. The patient 
was observed overnight in the EC. Eighteen hours post ingestion her 
tachypnoea worsened to 40 bpm and she developed hypoglycaemia, 
with a finger prick blood glucose reading of 1.8 mmol/L. Venous blood 
gas findings taken at room temperature at this time are shown in Table 1. 
Calculation of the anion gap was not possible because lactate 
and chloride values were not readily available. Based on the patient 
history and biochemical findings, a diagnosis of metabolic acidosis 
secondary to acute metformin overdose was made. 
Infusions of 5% dextrose w/v and 0.5% sodium bicarbonate were 
initiated separately, and the patient was immediately transferred to 
a secondary level hospital. Ongoing hypoglycaemia and worsening 
tachypnoea, accompanied by a drop in Glascow Coma Scale (GCS) 
to 12/15, occurred en route and 50 ml of a 50% dextrose bolus was 
administered. 
The patient developed a prolonged QT interval which precipitated 
cardiac arrest, with a GCS of 4T/15 requiring full resuscitation 
including inotropes. Arterial blood gas findings on 30% oxygen at 
this time revealed a metabolic acidosis as shown in Table 2. At that 
time her creatinine was 235 mmol/L and the calculated increased 
anion gap was 27.3. The patient was then transferred to a tertiary 
hospital for dialysis and intensive care unit (ICU) care. 
In the ICU, she had persistent refractory hypotension and worsen-
ing metabolic acidosis. Despite repeated doses of intravenous sodium 
bicarbonate and high-dose inotropic support, the GCS and metabolic 
acidosis remained unchanged. The patient died 42 hours post 
overdose despite aggressive ICU support.
Discussion
Metformin is a dimethylbiguanide. When prescribed in therapeutic 
doses for the management of type 2 diabetes mellitus, it is not 
known to cause hypoglycaemia. It is currently the only biguanide 
derivative available for this purpose. Two biguanides, phenformin 
and buformin, were removed from the market in the 1970s owing to 
their unpredictable association with lactic acidosis.[1,2] 
Sixty percent of ingested metformin is absorbed from the 
gastrointestinal tract (GIT), not metabolised, and is dependent 
on glomerular filtration for elimination. It is excreted in urine, 
therefore reduced estimated glomerular filtration rate will affect its 
excretion. Its mechanism of action is complex, including reduction of 
intestinal glucose absorption, inhibition of hepatic gluconeogenesis 
and enhanced peripheral insulin sensitivity.[1,3] 
Lactate is a byproduct of glucose and amino acid metabolism. Hyper-
lactataemia arises due to increased production or reduced metabolism of 
lactate.  The condition is broadly classified into two types:[4]  
• Type A: increased lactic acid in ischaemic tissue
• Type B: normal tissue perfusion in the presence of a mitochondrial 
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Table 1. Venous blood gas on room air
pH pCO2 pO2 HCO3 Base excess
6.9 11.7 kPa 8.9 kPa 23 mmol/L 3 mmol/L
Table 2. Arterial blood gas on 30% oxygen on arrival at the 
secondary hospital
pH pCO2 pO2 HCO3 Base excess
<6.8 1.5 kPa 22 kPa Not reported Not reported 
Table 3. Prescribed drugs associated with type B 
hyperlactataemia[5] 
Drug class Drug
Lipid lowering Statins
Fibrates
Analgesics Aspirin
Paracetamol
Anticonvulsants Sodium valproate
Biguanides Metformin
Anti-arrhythmic Amiodarone
Psychotropic Fluoxetine
Amitriptyline
Chlorpromazine
Haloperidol
Antiretroviral Stavudine
Didanosine
Zidovudine
111        February 2017, Vol. 107, No. 2
IN PRACTICE
defect (inherent or acquired secondary to 
pharmacotherapy). (Table 3)
Metformin-associated lactic acidosis 
(MALA) is a form of type B hyperlactataemia 
with a high anion gap. The estimated rate 
of MALA ranges between 3 and 9 cases 
per 100 000 patient-years with a mortality 
>50%.[6,7] 
Metformin inhibits gluconeogenesis by 
direct inhibition of pyruvate carboxylase, 
which causes pyruvate to accumulate 
and an increase in lactate production. It 
also inhibits oxidative phosphorylation, 
impairing generation of NAD+ from NADH 
by the mitochondria. This increase in NADH 
further favours conversion of pyruvate 
into lactate through inhibition of pyruvate 
dehydrogenase (Fig. 1).[8]
The resultant acidosis predisposes to 
dysrhythmias and diminished response to 
catecholamines.[9,10] This may explain why 
our patient had refractory hypotension 
despite high-dose inotropic support.
The management goals of MALA include 
restoration of acid-base status, removal 
of absorbed metformin and support of 
cardiovascular functions.[1] Knowledge of the 
pharmacokinetic properties of metformin 
is essential in formulating the management 
plan. Metformin is partially absorbed through 
the gastrointestinal tract, with the unabsorbed 
portion binding to the intestinal wall.[3] 
Activated charcoal is theoretically capable of 
binding the unabsorbed metformin[11] and 
should be administered early if the patient is 
awake and has a protected airway.                                                          
Management of lactic acidosis with the 
use of sodium bicarbonate (NaHCO3) is 
controversial despite its regular use.[1,2,9] 
Theoretical disadvantages are a leftward shift 
of the oxygen dissociation curve, worsening 
intracellular acidosis, rebound metabolic 
alkalosis and fluid overload.[1,2,9]  
Metformin overdose should be treated 
immediately. The drug is extensively ex -
creted renally and therefore haemodialysis 
is ideal in acute overdose for effective 
removal of both metformin and circulating 
lactate. [1,2,12] 
Conclusion
Acute metformin overdose is rare and 
potentially life threatening. Severe metabolic 
acidosis hypoglycaemia and cardiovascular 
collapse are the main clinical features. 
Patients should be treated promptly in a 
critical care unit, with early consideration 
for haemodialysis and cautious use of 
intravenous sodium bicarbonate.
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Fig. 1. Proposed mechanism for metformin-induced hyperlactataemia. (NADH = nicotinamide adenine 
dinucleotide, reduced form.)
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